title: Bortezomib in combination with dexamethasone for a young multiple myeloma with t(8; 14).
authors.forename: Jian-yong
authors.initials: JY
authors.lastname: Li
authors.forename: Li-xia
authors.initials: LX
authors.lastname: Wang
authors.forename: Wen-yi
authors.initials: WY
authors.lastname: Shen
authors.forename: Shi-feng
authors.initials: SF
authors.lastname: Lu
authors.forename: Li-juan
authors.initials: LJ
authors.lastname: Chen
authors.forename: Hua
authors.initials: H
authors.lastname: Lu
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D002883:Chromosomes, Human, Pair 14 / Q000235:genetics*; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics*; D003907:Dexamethasone / Q000008:administration & dosage; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D006811:Humerus / Q000473:pathology; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D011719:Pyrazines / Q000008:administration & dosage; D014178:Translocation, Genetic
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone